Trial Holdings Inc.

Equities

141A

JP3635490000

Discount Stores

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
2,709 JPY 0.00% Intraday chart for Trial Holdings Inc. +10.30% 0.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Quadrise continues work on MSAR, bioMSAR fuel trial deal AN
Tech Rally Subsides as US Equity Futures Waver Pre-Bell MT
Prime Medicine Gets FDA Clearance for PM359 IND Application DJ
Top Premarket Decliners MT
Dongcheng Biochemicals' Unit Gets Nod to Trial Tumor Drug MT
Eagle Eye wins one-year AI digital offering deal with Tesco Stores AN
Zenova wins GBP2.4 million paint contract with Drips & Sparks AN
Outperforming FTSE 100 spikes to another record AN
Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug MT
MannKind Gets FDA Clearance for Clofazimine IND Application DJ
AIM WINNERS & LOSERS: Mosman farm-in approved; Zenova's contract win AN
AstraZeneca makes progress with Truqap and Enhertu cancer treatments AN
AstraZeneca's Breast Cancer Drug Improves Progression-free Survival in Late-stage Study MT
AstraZeneca's Truqap Plus Faslodex Breast Cancer Treatment Bags EU Approval Recommendation MT
Hipgnosis Songs Fund backs new Blackstone bid AN
European Medicines Agency Committee Backs Roche's Subcutaneous Injection for Multiple Sclerosis MT
DISA Subsidiary Starts Trial Deployment of Vision Screening Tech in Vietnam MT
Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points MT
Russian journalist placed in pre-trial detention in alleged extremism case RE
Trump trial tests his campaign strategy of embracing bad publicity RE
'I have invited Biden to debate': Trump RE
Lawyers for Russia's deputy defence minister appeal his pre-trial detention, TASS reports RE
Pecker says he killed story to benefit Trump campaign RE
EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug MT
Biodexa Pharmaceuticals Gets Exclusive License for Phase 3 Ready Drug to Treat Familial Adenomatous Polyposis -- Shares Jump MT
Chart Trial Holdings Inc.
More charts
Trial Holdings Inc is a Japan-based holding company mainly engaged in the distribution and retail business and retail artificial intelligence (AI) business through its subsidiaries. The Company operates through two business segments. The Distribution and Retail segment mainly operates discount stores under the Trial brand that mainly provide daily necessities, home appliances, apparel goods, hobby goods, among others. Store formats include mega center, supercenter (SuC), smart and small store. The Retail Artificial Intelligence (AI) segment mainly provides products and solutions to retailers and food and consumer goods manufacturers that help improve customers' shopping experiences, physical store operations, and the efficiency of advertising and sales promotion activities. The Company also engages in resort-related businesses such as inn facilities and golf course management, as well as construction and real estate management business.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2,709 JPY
Average target price
3,200 JPY
Spread / Average Target
+18.12%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 141A Stock
  4. News Trial Holdings Inc.
  5. Sector Update: Health Care Stocks Steady Premarket Tuesday